TP53 and colorectal cancer: demonstrated that SIRT1 inhibits the activity of p53 via deacetylation; downregulates the expression of miR-101; and increases the level of KPNA3, thereby promoting the proliferation, migration and invasion of colorectal cancer and enhancing the resistance of tumors to the chemotherapy drug 5-FU (62).